A director at Raiffeisen Bank International AG sold 3,475 shares at 36.467EUR and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...
A director at Coca-Cola Hellenic Bottling Company AG sold 6,000 shares at 3,768p and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the las...
Despite its return to favour this year (+90% YTD vs SX7E +75%), we think the stock has re-rating potential that is still overlooked regarding RBI’s increasingly credible capacity to’ function’ decently without Russia, (the group’s key engine until 2022). Its solid outlook for profitability (ROE ~12% sur 2025-2028e, +7 pts vs 2024), and shareholder returns (dividend yield of ~6%, potential increase in the payout) and low valuation multiples (20% discount vs sector on P/E 2026e). We initiate cover...
En dépit d’un retour en grâce amorcé (+90% YTD vs SX7E +75%), il existe, selon nous, un potentiel de rerating encore mal identifié sur la capacité de plus en plus crédible de RBI à ‘fonctionner’ décemment sans la Russie (véritable locomotive du groupe jusqu’en 2022). Ses perspectives sont solides en matière de rentabilité (ROE ~12% sur 2025/28e, +7 pts vs 2024), et de retour à l’actionnaire (rendement dividende ~6%, potentielle hausse du payout)… le tout sur des multiples de valorisation bas (dé...
HEADLINES: • Poland macro: NBP cuts again, with inflation back at target • Wirtualna Polska: sells Invia Flights Germany at EUR 42.3m EV, 9.0x 2024 EV/EBITDA POSITIVE • WOOD's Winter Wonderland EME Conference 2025: Postcards from Prague • Allegro • Asseco Poland • Benefit Systems • Budimex • CCC • Kety • PGE • Tauron • Primoco UAV • Aquila Part Prod Com S.A. • MedLife • Mavi • Georgia Capital • GEVORKYAN • Krka • Medicover
A director at Bursa De Valori Bucuresti S A sold 3,500 shares at 40.873RON and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...
Two Directors at Med Life SA sold 1,000,000 shares at 8.800RON. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.